{"id":586,"date":"2026-03-02T14:16:27","date_gmt":"2026-03-02T14:16:27","guid":{"rendered":"https:\/\/efanet.org\/annual-report\/?page_id=586"},"modified":"2026-03-03T13:35:25","modified_gmt":"2026-03-03T13:35:25","slug":"immuniverse-precise-diagnosis-for-atopic-eczema","status":"publish","type":"page","link":"https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/","title":{"rendered":"ImmUniverse: precise diagnosis for atopic eczema"},"content":{"rendered":"
\n
\"\"<\/figure>\n<\/div>\n\n\n

ImmUniverse or \u201cBetter control and treatment of immune-mediateddiseases by exploring the universe of microenvironment imposed tissue signatures and theircorrelates in liquid biopsies\u201d<\/em> or is a project seeking to improve diagnostic and therapeutic options for patients living with immune-mediated inflammatory diseases, including atopic eczema. EFA coordinates a Patient Input Platform (PIP) together with the European Federation of Crohn\u2019s and Ulcerative Colitis Associations (EFCCA). The PIP is composed of 15 patients with atopic eczema and ulcerative colitis from 11 European countries, including members from EFA\u2019s Atopic Eczema Working Group.<\/p>\n\n\n\n

In 2022, EFA continued to work to ensure the patient centricity of the research, setting the basis for a stronger participation of the PIP throughout the project and a deeper involvement of patients in the research. In May, the PIP was involved in a meeting with the Principal Investigators (PIs) of the consortium. In June, a EFA representative joined the the first in-person Consortium Annual Meeting in Milan (Italy).  Besides the planned online and in-person meetings, the PIP was also consulted throughout the year.<\/p>\n\n\n\n

ImmUniverse: diagnosis and treatment for Atopic Eczema<\/strong><\/p>\n\n\n\n

Consortium: 26 organisations<\/p>\n\n\n\n

Countries<\/strong>: Italy, Switzerland, France, Belgium, Austria, Netherlands, Germany, Denmark, Luxembourg, and United Kingdom<\/p>\n\n\n\n

Research with an EFA\/EFCCA led Patient Input Platform (PIP) of 15 individuals<\/p>\n\n\n\n

Funded by Innovative Medicines Initiative (IMI2) No. 853995<\/p>\n\n\n\n

1 January 2020 \u2013 31 December 2025 – 60 months<\/p>\n\n\n\n

Website<\/a> \/ X (Twitter)<\/a><\/p>\n\n\n\n

<\/blockquote>\n","protected":false},"excerpt":{"rendered":"

ImmUniverse or \u201cBetter control and treatment of immune-mediateddiseases by exploring the universe of microenvironment imposed tissue signatures and theircorrelates in liquid biopsies\u201d or is a project seeking to improve diagnostic and therapeutic options for patients living with immune-mediated inflammatory diseases, including atopic eczema. EFA coordinates a Patient Input Platform (PIP) together with the European Federation […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":537,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page_2022.php","meta":{"_acf_changed":false,"inline_featured_image":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"class_list":["post-586","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nImmUniverse: precise diagnosis for atopic eczema - EFA - Annual Report<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ImmUniverse: precise diagnosis for atopic eczema - EFA - Annual Report\" \/>\n<meta property=\"og:description\" content=\"ImmUniverse or \u201cBetter control and treatment of immune-mediateddiseases by exploring the universe of microenvironment imposed tissue signatures and theircorrelates in liquid biopsies\u201d or is a project seeking to improve diagnostic and therapeutic options for patients living with immune-mediated inflammatory diseases, including atopic eczema. EFA coordinates a Patient Input Platform (PIP) together with the European Federation […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/\" \/>\n<meta property=\"og:site_name\" content=\"EFA - Annual Report\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/EFAPatients\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T13:35:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1113\" \/>\n\t<meta property=\"og:image:height\" content=\"780\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@EFA_Patients\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2022\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema\\\/\",\"url\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2022\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema\\\/\",\"name\":\"ImmUniverse: precise diagnosis for atopic eczema - EFA - Annual Report\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2022\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2022\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/35.-ImmUniverse_logo-300x210.png\",\"datePublished\":\"2026-03-02T14:16:27+00:00\",\"dateModified\":\"2026-03-03T13:35:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2022\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2022\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2022\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema\\\/#primaryimage\",\"url\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/35.-ImmUniverse_logo.png\",\"contentUrl\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/35.-ImmUniverse_logo.png\",\"width\":1113,\"height\":780},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2022\\\/care\\\/immuniverse-precise-diagnosis-for-atopic-eczema\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2022\",\"item\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2022-2\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Care: Our right for equal access to timely high quality care\",\"item\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/2022-2\\\/care\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"ImmUniverse: precise diagnosis for atopic eczema\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#website\",\"url\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/\",\"name\":\"EFA - Annual Report\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#organization\",\"name\":\"EFA\",\"url\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/EFA_logo_OFFICIAL.webp\",\"contentUrl\":\"http:\\\/\\\/efanet.org\\\/annual-report\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/EFA_logo_OFFICIAL.webp\",\"width\":1341,\"height\":742,\"caption\":\"EFA\"},\"image\":{\"@id\":\"https:\\\/\\\/efanet.org\\\/annual-report\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/EFAPatients\",\"https:\\\/\\\/x.com\\\/EFA_Patients\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/efanet\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ImmUniverse: precise diagnosis for atopic eczema - EFA - Annual Report","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/","og_locale":"en_GB","og_type":"article","og_title":"ImmUniverse: precise diagnosis for atopic eczema - EFA - Annual Report","og_description":"ImmUniverse or \u201cBetter control and treatment of immune-mediateddiseases by exploring the universe of microenvironment imposed tissue signatures and theircorrelates in liquid biopsies\u201d or is a project seeking to improve diagnostic and therapeutic options for patients living with immune-mediated inflammatory diseases, including atopic eczema. EFA coordinates a Patient Input Platform (PIP) together with the European Federation […]","og_url":"https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/","og_site_name":"EFA - Annual Report","article_publisher":"https:\/\/www.facebook.com\/EFAPatients","article_modified_time":"2026-03-03T13:35:25+00:00","og_image":[{"width":1113,"height":780,"url":"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@EFA_Patients","twitter_misc":{"Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/","url":"https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/","name":"ImmUniverse: precise diagnosis for atopic eczema - EFA - Annual Report","isPartOf":{"@id":"https:\/\/efanet.org\/annual-report\/#website"},"primaryImageOfPage":{"@id":"https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/#primaryimage"},"image":{"@id":"https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/#primaryimage"},"thumbnailUrl":"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo-300x210.png","datePublished":"2026-03-02T14:16:27+00:00","dateModified":"2026-03-03T13:35:25+00:00","breadcrumb":{"@id":"https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/#primaryimage","url":"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo.png","contentUrl":"https:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2026\/03\/35.-ImmUniverse_logo.png","width":1113,"height":780},{"@type":"BreadcrumbList","@id":"https:\/\/efanet.org\/annual-report\/2022\/care\/immuniverse-precise-diagnosis-for-atopic-eczema\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/efanet.org\/annual-report\/"},{"@type":"ListItem","position":2,"name":"2022","item":"https:\/\/efanet.org\/annual-report\/2022-2\/"},{"@type":"ListItem","position":3,"name":"Care: Our right for equal access to timely high quality care","item":"https:\/\/efanet.org\/annual-report\/2022-2\/care\/"},{"@type":"ListItem","position":4,"name":"ImmUniverse: precise diagnosis for atopic eczema"}]},{"@type":"WebSite","@id":"https:\/\/efanet.org\/annual-report\/#website","url":"https:\/\/efanet.org\/annual-report\/","name":"EFA - Annual Report","description":"","publisher":{"@id":"https:\/\/efanet.org\/annual-report\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/efanet.org\/annual-report\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/efanet.org\/annual-report\/#organization","name":"EFA","url":"https:\/\/efanet.org\/annual-report\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/efanet.org\/annual-report\/#\/schema\/logo\/image\/","url":"http:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2025\/05\/EFA_logo_OFFICIAL.webp","contentUrl":"http:\/\/efanet.org\/annual-report\/wp-content\/uploads\/2025\/05\/EFA_logo_OFFICIAL.webp","width":1341,"height":742,"caption":"EFA"},"image":{"@id":"https:\/\/efanet.org\/annual-report\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/EFAPatients","https:\/\/x.com\/EFA_Patients","https:\/\/www.linkedin.com\/company\/efanet\/"]}]}},"coauthors":[],"author_meta":{"author_link":"https:\/\/efanet.org\/annual-report\/author\/quentin\/","display_name":"quentin"},"relative_dates":{"created":"Posted 1 month ago","modified":"Updated 1 month ago"},"absolute_dates":{"created":"Posted on 2 March 2026","modified":"Updated on 3 March 2026"},"absolute_dates_time":{"created":"Posted on 2 March 2026 14:16","modified":"Updated on 3 March 2026 13:35"},"featured_img_caption":"","featured_img":false,"series_order":"","_links":{"self":[{"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages\/586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/comments?post=586"}],"version-history":[{"count":2,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages\/586\/revisions"}],"predecessor-version":[{"id":876,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages\/586\/revisions\/876"}],"up":[{"embeddable":true,"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/pages\/537"}],"wp:attachment":[{"href":"https:\/\/efanet.org\/annual-report\/wp-json\/wp\/v2\/media?parent=586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}